These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 8328186

  • 1. [Vascular occlusion and myocardial infarct].
    Schaper W.
    Z Kardiol; 1993; 82 Suppl 2():109-11. PubMed ID: 8328186
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Coronary thrombolysis with tissue-type plasminogen activator: an overview.
    Van de Werf F, Collen D.
    Eur Heart J; 1985 Nov; 6(11):902-4. PubMed ID: 3935445
    [No Abstract] [Full Text] [Related]

  • 4. The pig as a model for myocardial ischemia and exercise.
    White FC, Roth DM, Bloor CM.
    Lab Anim Sci; 1986 Aug; 36(4):351-6. PubMed ID: 3773444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B, Wang W, Zhao H, Hu D, Xu C, Zhao M, Lu M, Liu J, Wu C.
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [Abstract] [Full Text] [Related]

  • 8. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size.
    Charney R, Cohen M.
    Am Heart J; 1993 Oct; 126(4):937-45. PubMed ID: 8213453
    [Abstract] [Full Text] [Related]

  • 9. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
    G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
    [Abstract] [Full Text] [Related]

  • 10. [New substances and dosages for thrombolysis in acute myocardial infarct].
    Zeymer U, Neuhaus KL.
    Z Kardiol; 1993 Jan; 82 Suppl 2():137-41. PubMed ID: 8328192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G, Mailhac A, Li Volsi L, Di Marco F, Lu C, Margonato A, Chierchia SL.
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV, Sokrut VM, Shvyrenko IR.
    Fiziol Zh (1994); 1999 Oct; 45(6):26-30. PubMed ID: 10687078
    [Abstract] [Full Text] [Related]

  • 19. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
    Imperadore F, Spagnolli W, Martinelli L, Musuraca G, De Girolamo P, Maines M, Vergara G.
    Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.